ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,877.20
      1.72%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      80.005
      0.00%
      Bitcoin
      104,816.42
      0.38%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. OS Therapies Incorporated (OSTX) Quote

      OS Therapies Incorporated

      OS Therapies Incorporated (OSTX)

      AMEX
      2.95
      -1.17
      (-28.40%)
      Closed January 19 4:00PM
      Delayed by 15 minutes
      3.0101
      0.0601
      (2.04%)
      After Hours: 7:57PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      3.0101
      Bid
      -
      Ask
      -
      Volume
      1,632,130
      2.42 Day's Range 4.09
      1.58 52 Week Range 7.00
      Previous Close
      4.12
      Open
      4.09
      Last Trade
      6135
      @
      2.95
      Last Trade Time
      Average Volume (3m)
      413,946
      Financial Volume
      $ 5,183,091
      VWAP
      3.1757

      Ask ADVFN Intelligence (AI)

      OSTX Latest News

      More News

      Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

      January 17 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 17 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 15 2025
      Edgar (US Regulatory)

      OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma

      The primary endpoint of 12-month Event Free Survival (EFS) for OST-HER2- treated patients (33.3%) was statistically significant (p= 0.0158) when compared with peer-reviewed comparable historical...

      January 15 2025
      Business Wire

      OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma

      The primary endpoint of 12-month Event Free Survival (EFS) for OST-HER2- treated patients (33.3%) was statistically significant (p= 0.0158) when compared with peer-reviewed comparable historical...

      January 15 2025
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      January 14 2025
      Edgar (US Regulatory)

      Form 3 - Initial statement of beneficial ownership of securities

      January 14 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 14 2025
      Edgar (US Regulatory)

      Form EFFECT - Notice of Effectiveness

      January 14 2025
      Edgar (US Regulatory)

      Form S-8 - Securities to be offered to employees in employee benefit plans

      January 13 2025
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-2.3199-43.52532833025.3372.9839461894.35423051CS
      4-0.7099-19.08333333333.7272.9812075174.35998457CS
      120.03011.010067114092.9871.584139464.26000101CS
      26-0.9899-24.7475471.582880354.10430957CS
      52-0.9899-24.7475471.582880354.10430957CS
      156-0.9899-24.7475471.582880354.10430957CS
      260-0.9899-24.7475471.582880354.10430957CS

      OSTX - Frequently Asked Questions (FAQ)

      What is the current OS Therapies share price?
      The current share price of OS Therapies is $ 3.0101
      What is the 1 year trading range for OS Therapies share price?
      OS Therapies has traded in the range of $ 1.58 to $ 7.00 during the past year

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CHROChannel Therapeutics Corporation
      $ 1.90
      (97.92%)
      		14.27M
      GPUSHyperscale Data Inc
      $ 4.60
      (22.99%)
      		215.83k
      VINEFresh Vine Wine Inc
      $ 0.6899
      (22.98%)
      		376.38k
      RHERegional Health Properties Inc
      $ 2.40
      (18.81%)
      		227.57k
      MSTUT Rex 2X Long MSTR Daily Target ETF
      $ 13.245
      (16.80%)
      		62.46M
      FOXOFOXO Technologies Inc
      $ 0.2295
      (-27.14%)
      		11.34M
      OSTXOS Therapies Incorporated
      $ 3.03
      (-26.46%)
      		1.63M
      AEONAEON Biopharma Inc
      $ 0.1401
      (-18.02%)
      		29.86M
      MSTZT Rex 2X Inverse MSTR Daily Target ETF
      $ 12.56
      (-16.32%)
      		26.3M
      BOILProShares Ultra Bloomberg Natural Gas New
      $ 67.43
      (-14.52%)
      		3.87M
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 32.49
      (8.34%)
      		69.69M
      MSTUT Rex 2X Long MSTR Daily Target ETF
      $ 13.245
      (16.80%)
      		62.46M
      FXIiShares China Large Cap
      $ 30.40
      (1.91%)
      		59.69M
      SPYSPDR S&P 500
      $ 597.58
      (1.00%)
      		57.17M
      SOXSDirexion Daily Semiconductor Bear 3X Shares New
      $ 18.33
      (-8.03%)
      		53.86M

      OSTX Discussion

      View Posts
      tw0122 tw0122 4 days ago
      Didn't trade it but see you under $4 maybe lol thanks
      👍️0
      TheFinalCD TheFinalCD 4 days ago
      https://x.com/brentkhack_TX/status/1879510244243783831
      👍️0
      tw0122 tw0122 4 days ago
      Lung action $8s + 92% 17m floater 
      👍️0
      JPetroInc JPetroInc 4 months ago
      looking good Gerald...!

      IMHO, you'll have this trading at $0.00028 in record time



      here comes the Astoria Queens financial mafia wrecking crew to help assist you in your next financial debacle

      so much for running TOMDF into insolvency and jumping ship to this firm which didn't last long:

      Fortitude Advisors LLC

      https://fortitudeadvisors.com/team/

      "He is also the Chief Business Officer at OS Therapies, Inc. starting in 2024 and the Managing Partner at Fortitude Advisors LLC since 2019."

      https://uk.marketscreener.com/insider/GERALD-COMMISSIONG-A19LFK/

      I give Gerald Commissiong 6 months before OSTX fire's his arse - and for good measure...!

      MOO pathetic
      👍️0
      JPetroInc JPetroInc 4 months ago
      uh ho - Gerald Commissiong OSTX's new Chief Business Officer executive named...

      and is the same old same old serial dilution 'scam artist' from AMBS & TOMDF

      here we go again folks...!



      buyers be ware - check these other 2 tickers for the catastrophic results by this Stanford Univ. Financial Engineering hack

      https://ostherapies.com/leadership/

      SMH - can't make this stuff up - sad but true...!

      MOO tool
      👍️0

      Your Recent History

      AMEX
      OSTX
      OS Therapies
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads